CHARLES & COLVARD LTD (CTHR)
US1597652056 - Common Stock
Taking everything into account, CTHR scores 2 out of 10 in our fundamental rating. CTHR was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. While CTHR seems to be doing ok healthwise, there are quite some concerns on its profitability. CTHR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CTHR has reported negative net income.
CTHR had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CTHR reported negative net income in multiple years.
Of the past 5 years CTHR 4 years had a positive operating cash flow.
1.2 Ratios
CTHR's Return On Assets of -44.65% is on the low side compared to the rest of the industry. CTHR is outperformed by 92.00% of its industry peers.
Looking at the Return On Equity, with a value of -59.15%, CTHR is doing worse than 78.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.65% | ||
| ROE | -59.15% | ||
| ROIC | N/A |
ROA(3y)-5.63%
ROA(5y)-5.01%
ROE(3y)-7.41%
ROE(5y)-6.44%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 29.03%, CTHR is doing worse than 82.00% of the companies in the same industry.
CTHR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CTHR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.03% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.92%
GM growth 5Y-3.46%
2. Health
2.1 Basic Checks
CTHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTHR has been reduced compared to 1 year ago.
Compared to 5 years ago, CTHR has more shares outstanding
CTHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CTHR has an Altman-Z score of -1.64. This is a bad value and indicates that CTHR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CTHR (-1.64) is worse than 88.00% of its industry peers.
CTHR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
CTHR has a Debt to Equity ratio of 0.02. This is in the better half of the industry: CTHR outperforms 76.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.64 |
ROIC/WACCN/A
WACC8.82%
2.3 Liquidity
A Current Ratio of 2.47 indicates that CTHR has no problem at all paying its short term obligations.
CTHR has a Current ratio of 2.47. This is in the better half of the industry: CTHR outperforms 62.00% of its industry peers.
CTHR has a Quick Ratio of 1.26. This is a normal value and indicates that CTHR is financially healthy and should not expect problems in meeting its short term obligations.
CTHR has a Quick ratio of 1.26. This is comparable to the rest of the industry: CTHR outperforms 54.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.26 |
3. Growth
3.1 Past
CTHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.95%, which is quite impressive.
CTHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.69%.
Measured over the past years, CTHR shows a small growth in Revenue. The Revenue has been growing by 2.07% on average per year.
EPS 1Y (TTM)32.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)-29.69%
Revenue growth 3Y0.86%
Revenue growth 5Y2.07%
Sales Q2Q%-20.78%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y94.81%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
CTHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTHR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CTHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CHARLES & COLVARD LTD
NASDAQ:CTHR (12/3/2024, 12:05:29 PM)
1.2
-0.01 (-0.83%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.64M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.65% | ||
| ROE | -59.15% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.03% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.26 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)32.95%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y94.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-29.69%
Revenue growth 3Y0.86%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y